Clinical Trials Directory

Trials / Completed

CompletedNCT03161821

Circulating Tumor Cells in Solid Tumors

Quantification and Characterization of Circulating Tumor Cells in Solid Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
206 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify circulating tumor cells in patients with solid tumors. Quantify and characterize these cells, collect patient information in regards to the patient's cancer. Develop a database and a sample repository where future analysis could be done.

Detailed description

The primary purpose of this correlative study is to create a prospective database documenting the quantity and characterization of circulating tumor cells (CTCs) in solid tumor patients as identified by a various laboratory techniques and analyses. The investigators are developing this resource to provide data to achieve the following objectives: 1) correlate CTCs with known prognostic factors, 2) correlate CTCs with burden of disease, 3) evaluate the ability of CTCs to be used in the surveillance of disease recurrence, and 4) evaluate CTCs ability to be used as a biomarker for treatment response.

Conditions

Interventions

TypeNameDescription
OTHERObservational

Timeline

Start date
2011-12-09
Primary completion
2021-02-16
Completion
2021-02-16
First posted
2017-05-22
Last updated
2022-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03161821. Inclusion in this directory is not an endorsement.